Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers – The filing reports executive leadership or board composition changes and/or modifications to officer compensation arrangements as of August 31, 2026 Item 8.01: Regulation FD Disclosure – The company is making additional disclosures to…

Our analysis rates this filing NEUTRAL. This 8-K filing discloses planned executive leadership changes that represent normal organizational evolution rather than crisis management. The moderate concern level (3.5/10) reflects the inherent risks of leadership transitions in a major business segment,…

Concern level: MODERATE (3.5/10). Key factors: Executive leadership transition in significant business segment (International, Healthcare and Supply Chain Solutions) - Kate Gutmann retirement effective September 1, 2026; Organizational restructuring with multiple role changes (Cesarone to Chief Global Operations, Ramos promotion) creates near-term execution risk; Company deploying $9.0M in…

Notable risk changes: Kate Gutmann, EVP and President of International, Healthcare and Supply Chain Solutions, retiring effective September 1, 2026 with transitional role through March 31, 2027 - represents planned leadership transition in major business segment; Wilfredo Ramos appointed as replacement EVP/Chief International, Healthcare and Supply Chain Solutions Officer - internal promotion with 20+ years company…